Clinical Application of 68Ga-PSMA PET/MR for Diagnosis and Staging in Hepatocellular Carcinoma
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
In this prospective study, 68Ga-PSMA integrated PET/MR imaging was applied for the diagnosis
and staging of hepatocellular carcinoma (HCC). The detection and diagnostic performance of
68Ga-PSMA PET/MR for HCC was evaluated in comparison with the gold standard of puncture
biopsy or postoperative pathology. The aim is to make up for the deficiency in FDG PET
imaging in the diagnosis and staging of HCC.